Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide, quantity: 40 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; maize starch; sunset yellow fcf; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc - frumil is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

Malta - English - Medicines Authority

wockhardt uk limited - amiloride hydrochloride; furosemide - tablet - amiloride hydrochloride; furosemide - diuretics

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - amiloride hydrochloride, furosemide - tablet - amiloride hydrochloride 5.68 mg furosemide 40 mg - diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

norton healthcare limited t/a ivax pharmaceuticals uk - furosemide, amiloride hydrochloride - tablets - 40/5 milligram - high-ceiling diuretics and potassium-sparing agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - amiloride hydrochloride; furosemide - oral tablet - 2.5mg ; 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - amiloride hydrochloride; furosemide - oral tablet - 5mg ; 40mg

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - furosemide ; amiloride hydrochloride - tablet - 40mg /5 milligram(s) - high-ceiling diuretics and potassium-sparing agents; furosemide and potassium-sparing agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - amiloride hydrochloride; furosemide - oral suspension - 2mg/1ml ; 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - amiloride hydrochloride; furosemide - oral solution - 2mg/1ml ; 25mg/1ml

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amiloride hydrochloride anhydrous 5 mg - amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone, or in whom maintenance of normal serum potassium levels is considered to be clinically important, e.g., digitalized patients, or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs, such as methyldopa or beta blockers. since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents, dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects. this fixed combination drug is not indicated for the initial therapy of edema or hyper